Bellevue Asset Management (Switzerland)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$4.13M Hold
60,000
0.63% 55
2015
Q3
$3.55M Hold
60,000
0.58% 54
2015
Q2
$3.99M Hold
60,000
0.55% 61
2015
Q1
$3.87M Buy
+60,000
New +$3.76M 0.54% 60

Other funds holding BMY

Bellevue Asset Management (Switzerland)'s BMY Position: Q4 2015 in Review

Bellevue Asset Management (Switzerland) held its Bristol-Myers Squibb (BMY) position steady in Q4 2015 at 60,000 shares worth $4.13M. The position accounts for 0.63% of the portfolio, ranked #55.

Bellevue Asset Management (Switzerland) first reported a position in BMY in Q1 2015 and has held it in 4 quarters since. 1,535 funds tracked by Wall St. Rank hold BMY as of Q4 2015.

  • Bellevue Asset Management (Switzerland) held 60,000 shares of Bristol-Myers Squibb worth $4.13M as of Q4 2015.
  • Bellevue Asset Management (Switzerland) left its Bristol-Myers Squibb share count unchanged in Q4 2015.
  • Bristol-Myers Squibb made up 0.63% of Bellevue Asset Management (Switzerland)'s portfolio in Q4 2015, its #55 holding.
  • Bellevue Asset Management (Switzerland) first reported a position in Bristol-Myers Squibb in Q1 2015 and has held it in 4 quarters since.
  • 1,535 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.